Rivaroxaban in elective percutaneous coronary intervention to treat stable coronary artery disease

被引：0
|
作者：
Verheugt, F. W. A. [1 ]
Vranckx, P. [2 ]
Lindeboom, W.
Kim, S. Y. [3 ]
Kirsch, B. [3 ]
Van Eickels, M. [3 ]
Leebeek, F. W. G. [4 ]
机构：
[1] Hosp Onze Lieve Vrouwe Gasthuis, Amsterdam, Netherlands
[2] Jessa Hosp, Hasselt, Belgium
[3] Bayer HealthCare, Leverkusen, Germany
[4] Erasmus MC, Rotterdam, Netherlands
来源：
EUROPEAN HEART JOURNAL | 2014年 / 35卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P5520
引用
收藏
页码：992 / 992
页数：1
相关论文
共 50 条
  • [1] Benefit of elective percutaneous coronary intervention for stable coronary artery disease
    Ennezat, Pierre Vladimir
    Malergue, Marie-Christine
    Czitrom, Daniel
    Marechaux, Sylvestre
    Tricot, Olivier
    Le Jemtel, Thierry H.
    Vincentelli, Andre
    [J]. PRESSE MEDICALE, 2019, 48 (10): : 1037 - 1042
  • [2] Peri-procedural use of rivaroxaban in elective percutaneous coronary intervention to treat stable coronary artery disease The X-PLORER trial
    Vranckx, Pascal
    Leebeek, Frank W. G.
    Tijssen, Jan G. P.
    Koolen, Jacques
    Stammen, Francis
    Herman, Jean-Paul R.
    de Winter, Robbert J.
    van t Hof, Arnout W. J.
    Backx, Bianca
    Lindeboom, Wietze
    Kim, So-Young
    Kirsch, Bodo
    van Eickels, Martin
    Misselwitz, Frank
    Verheugt, Freek W. A.
    [J]. THROMBOSIS AND HAEMOSTASIS, 2015, 114 (02) : 258 - 267
  • [3] Percutaneous coronary intervention for stable coronary artery disease
    Katritsis, Demosthenes G.
    Meier, Bernhard
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2008, 52 (11) : 889 - 893
  • [4] Percutaneous coronary intervention for stable coronary artery disease
    Al-Lamee, Rasha K.
    Nowbar, Alexandra N.
    Francis, Darrel P.
    [J]. HEART, 2019, 105 (01) : 11 - 19
  • [5] Percutaneous coronary intervention in stable coronary artery disease
    Piroth Zsolt
    [J]. ORVOSI HETILAP, 2014, 155 (49) : 1952 - 1959
  • [6] A randomised study of dabigatran in elective percutaneous coronary intervention in stable coronary artery disease patients
    Vranckx, Pascal
    Verheugt, Freek W. A.
    de Maat, Moniek P.
    Ulmans, Victor A. W. M.
    Regar, Evelyn
    Smits, Peter
    ten Berg, Jurrien M.
    Lindeboom, Wietze
    Jones, Russel L.
    Friedman, Jeffrey
    Reilly, Paul
    Leebeek, Frank W. G.
    [J]. EUROINTERVENTION, 2013, 8 (09) : 1052 - 1060
  • [7] Update on Percutaneous Coronary Intervention in Stable Coronary Artery Disease
    Mitchell, Joshua D.
    Brown, David L.
    [J]. JAMA INTERNAL MEDICINE, 2016, 176 (12) : 1855 - 1856
  • [8] Current medical management of stable coronary artery disease before and after elective percutaneous coronary intervention
    Ardati, Amer K.
    Pitt, Bertram
    Smith, Dean E.
    Aronow, Herbert D.
    Share, David
    Moscucci, Mauro
    Chetcuti, Stanley
    Grossman, P. Michael
    Gurm, Hitinder S.
    [J]. AMERICAN HEART JOURNAL, 2013, 165 (05) : 778 - 784
  • [9] Inflammatory response to percutaneous coronary intervention in stable coronary artery disease
    Peter S. Munk
    Unni M. Breland
    Pål Aukrust
    Oyvind Skadberg
    Thor Ueland
    Alf I. Larsen
    [J]. Journal of Thrombosis and Thrombolysis, 2011, 31 : 92 - 98
  • [10] Effects of percutaneous coronary intervention on dyspnea in stable coronary artery disease
    Wester, Michael
    Koll, Franziska
    Luedde, Mark
    Langer, Christoph
    Resch, Markus
    Luchner, Andreas
    Mueller, Karolina
    Zeman, Florian
    Koller, Michael
    Maier, Lars S.
    Sossalla, Samuel
    [J]. CLINICAL RESEARCH IN CARDIOLOGY, 2023, 112 (09) : 1194 - 1203
12345